CACrown ArchivesThe cinema collection
Menu
Research dossier · General Reference

Cystic fibrosis transmembrane conductance regulator

mammalian protein found in Homo sapiens

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionSep 15, 2026
Entity authorityQ420470 ↗
Source-derived summary

Cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein and anion channel in vertebrates that is encoded by the CFTR gene.

Geneticist Lap-Chee Tsui and his team identified the CFTR gene in 1989 as the gene linked with cystic fibrosis.

The CFTR gene codes for an ABC transporter-class ion channel protein that conducts chloride and bicarbonate ions across epithelial cell membranes. Mutations of the CFTR gene affecting anion channel function lead to dysregulation of epithelial lining fluid (mucus) transport in the lung, pancreas and other organs, resulting in cystic fibrosis. Complications include thickened mucus in the lungs with frequent respiratory infections, and pancreatic insufficiency giving rise to malnutrition and diabetes. These conditions lead to chronic disability and reduced life expectancy. In male patients, the progressive obstruction and destruction of the developing vas deferens (spermatic cord) and epididymis appear to result from abnormal intraluminal secretions, causing congenital absence of the vas deferens and male infertility, and found associated with an imbalance of fatty acids.

Tissue and intracellular localization

The CFTR is found in the epithelial cells of many organs including the lung, liver, pancreas, digestive tract, and the female reproductive tract and male reproductive tract including the testis, Sertoli cells, spermatozoa. epididymis, and the vas deferens.

In the airways of the lung, CFTR is most highly expressed by rare specialized cells called pulmonary ionocytes.

Editorial summary

“Cystic fibrosis transmembrane conductance regulator” enters the record as mammalian protein found in Homo sapiens. Crown Archives preserves that source wording while asking what Cystic, fibrosis and transmembrane can confirm, complicate or overturn.

Editorial reviewA dependable orientation record for establishing vocabulary, names and a first evidence trail. The current lead gives the account dated anchors—1989—that can be checked directly. The selected authority fields contribute no independent date. Its strongest next move is a source search built around Cystic, fibrosis and transmembrane.
Editorial analysis

Why this record matters

“Cystic fibrosis transmembrane conductance regulator” is worth following because a concise public description often conceals a longer documentary argument. Here, Cystic, fibrosis and transmembrane provides the most credible route into that argument.

Evidence profile

The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Sep 15, 2026. The linked authority identifier is Q420470. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1989.

Critical limits

The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “Cystic fibrosis transmembrane conductance regulator”, its source revision and the description used here.
  2. Expand the search: follow Cystic fibrosis transmembrane conductance regulator primary sources, Cystic fibrosis transmembrane conductance regulator archive and Cystic research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Cystic fibrosis transmembrane conductance regulator”?
  2. Which cited source is closest to the event, object or claim?
  3. Which institution is responsible for the underlying evidence?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “Cystic fibrosis transmembrane conductance regulator” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.